ALLK - Why Allakos Stock Plummeted 87.5% in the Last Month of 2021
Allakos (NASDAQ: ALLK) stock sank 87.5% in December, according to data from S&P Global Market Intelligence . The clinical-stage biotech company's share price plummeted after the publication of disappointing trial data for its key treatment.
For further details see:
Why Allakos Stock Plummeted 87.5% in the Last Month of 2021